Antonio Medina de Almeida


AuthID: R-000-T91

Confirmed Publications: 65



31
TITLE: Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
AUTHORS: Antonio Almeida ; Thomas Prebet; Raphael Itzykson; Fernando Ramos; Haifa Al-Ali; Jamile Shammo; Ricardo Pinto; Luca Maurillo; Jaime Wetzel; Pellegrino Musto; Arjan Van De Loosdrecht; Maria Costa; Susana Esteves; Sonja Burgstaller; Reinhard Stauder; Eva Autzinger; Alois Lang; Peter Krippl; Dietmar Geissler; Jose Falantes; Carmen Pedro; Joan Bargay; Guillermo Deben; Ana Garrido; Santiago Bonanad; Maria Diez-Campelo; Sylvain Thepot; Lionel Ades; Wolfgang Sperr; Peter Valent; Pierre Fenaux; Mikkael Sekeres; Richard Greil; Lisa Pleyer; ...More
PUBLISHED: 2017, SOURCE: International Journal of Molecular Sciences, VOLUME: 18, ISSUE: 4
INDEXED IN: CrossRef: 19
IN MY: ORCID | CIÊNCIAVITAE
32
TITLE: Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study
AUTHORS: António Almeida ; Ana Rita Ferreira; Maria João Costa; Sofia Silva; Khalil Alnajjar; Isabel Bogalho; Francesca Pierdomenico; Susana Esteves; Mafalda Alpoim; Gil Braz; Emilia Cortesão; Ricardo Pinto;
PUBLISHED: 2017, SOURCE: Leukemia Research Reports, VOLUME: 7
INDEXED IN: CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
33
TITLE: Clinical outcomes of AML patients treated with Azacitidine in Portugal: A retrospective multicenter study
AUTHORS: António Almeida ; Ana Rita Ferreira; Maria João Costa; Sofia Silva; Khalil Alnajjar; Isabel Bogalho; Francesca Pierdomenico; Susana Esteves; Mafalda Alpoim; Gil Braz; Emilia Cortesão; Ricardo Pinto;
PUBLISHED: 2017, SOURCE: Leukemia Research Reports, VOLUME: 7
INDEXED IN: Scopus
IN MY: ORCID | CIÊNCIAVITAE
34
TITLE: Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients
AUTHORS: Urbano Ispizua, Á; Muus, P; Schrezenmeier, H; Almeida, AM ; Wilson, A; Ware, RE;
PUBLISHED: 2017, SOURCE: Haematologica, VOLUME: 102, ISSUE: 3
INDEXED IN: Scopus
IN MY: ORCID | CIÊNCIAVITAE
35
TITLE: HDAC8 overexpression in mesenchymal stromal cells from JAK2(+) myeloproliferative neoplasms: a new therapeutic target?
AUTHORS: Ramos, TL; Sanchez Abarca, LI; Redondo, A; Hernandez Hernandez, A; Almeida, AM ; Puig, N; Rodriguez, C; Ortega, R; Preciado, S; Rico, A; Muntion, S; Porras, JRG; Del Canizo, C; Sanchez Guijo, F;
PUBLISHED: 2017, SOURCE: ONCOTARGET, VOLUME: 8, ISSUE: 17
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID | CIÊNCIAVITAE
36
TITLE: Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)
AUTHORS: Almeida, A ; Fenaux, P; List, AF; Raza, A; Platzbecker, U; Santini, V;
PUBLISHED: 2017, SOURCE: LEUKEMIA RESEARCH, VOLUME: 52
INDEXED IN: Scopus WOS CrossRef: 23
IN MY: ORCID | CIÊNCIAVITAE
37
TITLE: Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and poor prognosis due to red blood cell transfusion–dependent anemia and thrombocytopenia
AUTHORS: Guillermo Garcia-Manero; Antonio Almeida ; Aristoteles Giagounidis; Uwe Platzbecker; Regina Garcia; Maria Teresa Voso; Stephen R Larsen; David Valcarcel; Lewis R Silverman; Barry Skikne; Valeria Santini;
PUBLISHED: 2016, SOURCE: BMC Hematology, VOLUME: 16, ISSUE: 1
INDEXED IN: CrossRef: 31
IN MY: ORCID | CIÊNCIAVITAE
38
TITLE: Design and rationale of the QUAZAR lower-risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and poor prognosis due to red blood cell transfusion–dependent anemia and thrombocytopenia
AUTHORS: Guillermo Garcia Manero; Antonio Almeida ; Aristoteles Giagounidis; Uwe Platzbecker; Regina Garcia; Maria Teresa Voso; Stephen R Larsen; David Valcarcel; Lewis R Silverman; Barry Skikne; Valeria Santini;
PUBLISHED: 2016, SOURCE: BMC Hematology, VOLUME: 16, ISSUE: 1
INDEXED IN: Scopus
IN MY: ORCID | CIÊNCIAVITAE
39
TITLE: Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia
AUTHORS: Roboz, GJ; Montesinos, P; Selleslag, D; Wei, A; Jang, JH; Falantes, J; Voso, MT; Sayar, H; Porkka, K; Marlton, P; Almeida, A ; Mohan, S; Ravandi, F; Garcia Manero, G; Skikne, B; Kantarjian, H;
PUBLISHED: 2016, SOURCE: FUTURE ONCOLOGY, VOLUME: 12, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID | CIÊNCIAVITAE
40
TITLE: Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients
AUTHORS: Álvaro Urbano-Ispizua; Petra Muus; Hubert Schrezenmeier; Antonio M Almeida ; Amanda Wilson; Russell E Ware;
PUBLISHED: 2016, SOURCE: Haematologica, VOLUME: 102, ISSUE: 3
INDEXED IN: CrossRef: 16
IN MY: ORCID | CIÊNCIAVITAE
Page 4 of 7. Total results: 65.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service